Nano2Life The European Network of Excellence in Nanobiotech Dr Dimitris Tsamouras, FORTH / HELP-FORWARD Athens, October 12, 2005 Nanobiotechnology or Bionanotechnology ? Nano-biotechnology is used when nano- applies its revolutionary principles to life sciences: nano-structured materials, taking advantage of specific properties due to the nanoscale can interact precisely with biomolecules or cells, either targeting some specific molecules or detecting molecular events; nano-tools for exploration of matter at the atomic or molecular levels can highlight some specific properties of biological complex architectures, especially their dynamic behavior. So we can (or try to): Analyse biological samples (fluids, molecules) thanks to highly integrated and miniaturised devices Label and track single molecules or trace elements Target and deliver drugs with a better efficiency and less side effects Improve the fabrication of novel nanostructured materials
13
Embed
N2L BDay presentation Tsamouras - PRAXI Networkpraxinetwork.gr/el/doclib/hbc/HF.pdf · the field based on the requests from the SRP-Application groups • 6 Application driven groups
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Nano2LifeThe European Network of Excellencein Nanobiotech
Dr Dimitris Tsamouras, FORTH / HELP-FORWARDAthens, October 12, 2005
Nanobiotechnology or Bionanotechnology ?Nano-biotechnology is used when nano- applies its revolutionary
principles to life sciences:� nano-structured materials, taking advantage of specific properties
due to the nanoscale can interact precisely with biomolecules or cells, either targeting some specific molecules or detecting molecular events;
� nano-tools for exploration of matter at the atomic or molecular levels can highlight some specific properties of biological complex architectures, especially their dynamic behavior.
So we can (or try to):� Analyse biological samples (fluids, molecules) thanks to highly
integrated and miniaturised devices� Label and track single molecules or trace elements� Target and deliver drugs with a better efficiency and less side effects� Improve the fabrication of novel nanostructured materials
Current situation in EU Nanobiotech
� Fragmented� Various duplicates� Limited industrial investment in R&D� Sub-critical size� Ignorance
N2L mission
� To merge the existing European expertise and knowledge in the field of NanoBiotech
� To improve European scientific excellence and industrial competitiveness in the same sector
Long term goals
1. A scientific excellence centre in NanoBiotech
2. A reference centre for industry and appliedresearch
3. A trend-setter for new research and standards
Some key figures
� 23 full partners� 40 associate partners� 12 countries (incl. CH and IS)� More than 200 scientists� EC Contract for 4 years� EC grant: € 8.8 M � Total budget: € 15 M
Uni Lund
EPFL Lausanne, FSRM
MIC Copenhagen
Parc Cientifica Barcelona
Uni Münster, Centech, Bioanalytik, Uni Mainz, Uni Saarland, Uni KaiserslauternNanoBioNet, IBMT
JRC Ispra
Demokritos, FORTH
Mesa+ / Uni Twente
Tyndall institute
INSAT Newcastle
CEA, CNRS, INSERM
Uni Tel Aviv
A motivated consortium
Strategy
General Activities
� Shared resources & Mobility (WP1)
� Joint Research Programme (WP7)
� Education (WP8)
� Project Management (WP10)
4 support instruments
� Industrial cooperation (WP6)
� IPR & Knowledge management (WP2 / led by FORTH)
� Gender Action Plan (WP3)
� Communication & dissemination (WP9)
Horizontal actions
� Ethics (WP4)
� Foresight & Strategy (WP5)
18 months of activity
� 4 large scientific meetings with more than 100 scientists
� 6 Executive Board meetings
� 20 joint projects initiated
� 12 fellowships for education
� 17 grants for initiating and supporting new projects
� 1 State of the Art (200 pages!!)
� 1 data base on equipment
� 2 web sites (internal / public)
3 core activities� Incubation of joint research projects